文献速递腹部介入MR

多期MRI衍生的Delta影像组学结合临床特征预测肝细胞癌热消融后生存

Multiphase MRI-Derived Delta radiomics integrated with clinical features for survival prediction in hepatocellular carcinoma after thermal ablation.
PubMed 文献 · Eur J Radiol · 2025-08-18

这项回顾性研究纳入两个中心415例接受多期增强MRI和经皮热消融的肝细胞癌患者,从对比增强期与非增强图像的比较中提取Delta影像组学特征构建Delta影像组学评分,并结合肿瘤负荷评分、巴塞罗那临床肝癌分期和中国肝癌分期等临床特征建立随机生存森林模型,用于预测总生存期和无复发生存期,模型在内部和外部验证中显示出良好的预测性能和临床效用。

要点

  • Delta影像组学评分结合肿瘤负荷评分、BCLC和CNLC等临床特征构建的随机生存森林模型可预测热消融后总生存期和无复发生存期。
  • 总生存期预测在36和60个月时AUC为0.71至0.83,C指数为0.69至0.83,内部和外部验证均显示良好性能。
  • 短期无复发生存期预测在6、12和24个月时AUC为0.71至0.91,C指数为0.68至0.71。

核心结论

  • 多期MRI衍生的Delta影像组学能有效捕捉肿瘤动态和异质性,与临床特征整合后的模型可准确预测复发和长期生存,为肝细胞癌风险分层和个体化消融后管理提供实用工具。

研究设计与样本

  • 回顾性研究,纳入两个中心共415例接受多期增强MRI和经皮热消融的肝细胞癌患者,中心1的315例随机分为训练队列220例和内部测试队列95例,中心2的100例组成外部验证队列。

关键影像表现/征象

  • Delta影像组学特征通过比较增强期与非增强图像提取,经方差过滤、相关性分析、随机森林排序和Cox回归得到Delta影像组学评分。
  • Delta影像组学评分与肿瘤负荷评分、巴塞罗那临床肝癌分期和中国肝癌分期等临床特征结合构建随机生存森林模型。

诊断标准与关键数值

  • 总生存期预测在36和60个月时,各队列AUC为0.71至0.83,C指数为0.69至0.83。
  • 短期无复发生存期预测在6、12和24个月时,AUC为0.71至0.91,C指数为0.68至0.71。
  • 校准曲线和决策曲线分析证实模型在内部和外部验证中的稳健性和临床效用。

临床应用与阅片要点

  • 多期增强MRI的Delta影像组学评分结合肿瘤负荷评分、巴塞罗那临床肝癌分期和中国肝癌分期等临床特征,可用于肝细胞癌热消融后总生存期和无复发生存期的风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate the predictive value of a delta radiomic score (DRS)derived from multiphase contrast-enhanced Magnetic Resonance Imaging (MRI), in combination with clinical characteristics, forecasting overall survival (OS) and recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) after thermal ablation.

MATERIALS AND METHODS: This retrospective study enrolled 415 patients with HCC from two centers who underwent multiphase contrast-enhanced magnetic resonance imaging and percutaneous thermal ablation. Patients in Institution 1 (n = 315) were randomly assigned to the training cohorts (n = 220) and internal tests (n = 95), while 100 patients in Institution 2 formed the external validation cohort. Delta radiomic features were extracted by comparing contrast-enhanced phases with noncontract images, followed by variance filtering, correlation analysis, random forest ranking, and Cox regression to derive the DRS. The DRS was combined with clinical characteristics, including tumor burden score (TBS), Barcelona Clinic Liver Cancer (BCLC), and China Liver Cancer Staging (CNLC), to build Random Survival Forest (RSF) models. The performance of the model was evaluated using the concordance index (C-index), the area under the curve (AUC), the calibration curves and the analysis of decision curves (DCA).

RESULTS: The RSF models that integrate DRS with clinical characteristics demonstrated favorable predictive performance for both OS and RFS. For OS predictions at 36 and 60 months, AUCs ranged from 0.71 to 0.83 in cohorts, with corresponding C indices between 0.69 and 0.83. For the prediction of short-term RFS at 6, 12, and 24 months, the AUC ranged from 0.71 to 0.91, with C-indices between 0.68 and 0.71. Calibration and DCA analysis confirmed the robustness and clinical utility of the models in internal and external validations.

CONCLUSIONS: Delta radiomics derived from multiphase MRI effectively captured tumor dynamics and heterogeneity. When integrated with clinical characteristics, the resulting models allowed an accurate prediction of both recurrence and long-term survival, providing a practical tool for risk stratification and individualized post-ablation management in HCC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Luo J, Xin H, Wang Y, et al. Multiphase MRI-Derived Delta radiomics integrated with clinical features for survival prediction in hepatocellular carcinoma after thermal ablation. Eur J Radiol. 2025. PMID: 40849993. doi:10.1016/j.ejrad.2025.112368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。